Carboplatin

Form: Injection

Strength: 50 mg/5 mL , 150 mg/15 mL, 450 mg/45 mL

Reference Brands: Paraplatin® (EU & US)

Category: Oncology Cancer Care

Carboplatin, marketed as Paraplatin®, is a platinum-based chemotherapy agent used in the treatment of various cancers, including ovarian, lung, head and neck, testicular, and bladder cancer. It is administered intravenously in 50 mg/5 mL, 150 mg/15 mL, and 450 mg/45 mL formulations. Carboplatin interferes with the DNA of cancer cells, preventing their division and growth. Manufactured under stringent GMP regulations, it offers key opportunities for B2B oncology pharmaceutical companies targeting hospitals, oncology clinics, and cancer treatment centers in the US and EU markets.